نمایش مختصر رکورد

dc.contributor.authorPourghahreman, Nargesen_US
dc.contributor.authorRajabzadeh Ghatari, Alien_US
dc.contributor.authorMoosivand, Asiyeen_US
dc.date.accessioned1399-07-09T07:00:03Zfa_IR
dc.date.accessioned2020-09-30T07:00:03Z
dc.date.available1399-07-09T07:00:03Zfa_IR
dc.date.available2020-09-30T07:00:03Z
dc.date.issued2018-10-01en_US
dc.date.issued1397-07-09fa_IR
dc.date.submitted2016-04-03en_US
dc.date.submitted1395-01-15fa_IR
dc.identifier.citationPourghahreman, Narges, Rajabzadeh Ghatari, Ali, Moosivand, Asiye. (2018). Agent Based Simulation of Sale and Manufacturing Agents Acting Across a Pharmaceutical Supply Chain. Iranian Journal of Pharmaceutical Research, 17(4), 1581-1592. doi: 10.22037/ijpr.2018.2309en_US
dc.identifier.issn1735-0328
dc.identifier.issn1726-6890
dc.identifier.urihttps://dx.doi.org/10.22037/ijpr.2018.2309
dc.identifier.urihttp://ijpr.sbmu.ac.ir/article_2309.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/313535
dc.description.abstractAgent based modeling and simulation consider the behavior of agents acting in a system. The agents' interactions result in changing the agent's behavior, the whole agent based system, and its environment. In this study, the manufacturing, sale, and receiving orders behaviors pertinent to manufacturing and sale agents acting across a pharmaceutical supply chain of an Iranian manufacturing medicine (as a case) are simulated. The departments related to these two agents have some problems affecting the entire supply chain; the results are interpreted based on agile, lean, and green paradigms. During the research, three medicines were selected and the related data were gathered. Then, mathematical modeling and regression analysis (in some parts) were applied. Next, a computer model was composed on matrix library environment (MATLAB). Finally, four scenarios were simulated. According to the information resulted from simulating the first scenario, none of supply chains pertaining to each medicine is agile. Based on the findings of simulating the second scenario, decreasing waste leads the non-antibiotic medicine supply chain to move toward the lean and green paradigms more. According to the third scenario, although more order requests can be fulfilled by increasing production capacity, the supply chain will not become agile. The last scenario's goal is checking the possibility of receiving 145000 units' orders for the non-antibiotic medicine which should be prepared during next 70 days while the company confronts lack of raw material and the suppliers are domestic; based on the results, the order will be rejected due to lack of time.en_US
dc.format.extent830
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoen_US
dc.publisherSchool of Pharmacy, Shahid Beheshti University of Medical Sciencesen_US
dc.relation.ispartofIranian Journal of Pharmaceutical Researchen_US
dc.relation.isversionofhttps://dx.doi.org/10.22037/ijpr.2018.2309
dc.subjectAgent based simulationen_US
dc.subjectCase studyen_US
dc.subjectMathematical modelingen_US
dc.subjectRegression analysisen_US
dc.subjectPharmaceutical industryen_US
dc.subjectIranen_US
dc.subjectcomputional and modellingen_US
dc.titleAgent Based Simulation of Sale and Manufacturing Agents Acting Across a Pharmaceutical Supply Chainen_US
dc.typeTexten_US
dc.typeResearch articleen_US
dc.contributor.departmentDepartment of Information Technology Management, Science and Research Branch, Islamic Azad University, Tehran, Iran.en_US
dc.contributor.departmentDepartment of Management, Faculty of Management and Economic, Tarbiat Modares University, Tehran, Iran.en_US
dc.contributor.departmentDepartment of Pharmacoeconomy and Administrative Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Science, Tehran, Iran.en_US
dc.citation.volume17
dc.citation.issue4
dc.citation.spage1581
dc.citation.epage1592


فایل‌های این مورد

Thumbnail

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد